Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2017-12-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2017.11.010PMID 29153737PMCID PMC5705205
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combating breast cancer with non-steroidal aromatase inhibitors (NSAIs): Understanding the chemico-biological interactions through comparative SAR/QSAR study.

  2017cited by this paper
• Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.

  2016cited by this paper
• Inhibition of Testosterone Aromatization by the Indole-3-carbinol Derivative CTet in CYP19A1-overexpressing MCF-7 Breast Cancer Cells.

  2015cited by this paper
• Design, synthesis and aromatase inhibitory activities of novel indole-imidazole derivatives.

  2013cited by this paper
• Hallmarks of aromatase inhibitor drug resistance revealed by epigenetic profiling in breast cancer.

  2013cited by this paper
• Synthesis of 2-arylindole derivatives and evaluation as nitric oxide synthase and NFκB inhibitors.

  2012cited by this paper
• Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol.

  2012cited by this paper
• Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1).

  2012cited by this paper
• Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.

  2012cited by this paper
• New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series.

  2012cited by this paper
• Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates

  2011cited by this paper
• Binding features of steroidal and nonsteroidal inhibitors.

  2011cited by this paper
• Current role and safety profile of aromatase inhibitors in early breast cancer

  2011cited by this paper
• Structure-based design of potent aromatase inhibitors by high-throughput docking.

  2011cited by this paper
• Marine indole alkaloids: potential new drug leads for the control of depression and anxiety.

  2010cited by this paper
• Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia.

  2009cited by this paper
• From nonsteroidal aromatase inhibitors to multifunctional drug candidates: classic and innovative strategies for the treatment of breast cancer.

  2008cited by this paper
• Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors.

  2008cited by this paper
• Ligand configurational entropy and protein binding

  2007cited by this paper
• Synthesis and biological evaluation of 3-(azolylmethyl)-1H-indoles and 3-(α-azolylbenzyl)-1H-indoles as selective aromatase inhibitors

  2007cited by this paper
• Quinone reductase induction as a biomarker for cancer chemoprevention.

  2006cited by this paper
• Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: potent and selective aromatase inhibitors.

  2006cited by this paper
• Aromatase and breast cancer.

  2006cited by this paper
• Aromatase inhibitors in the treatment of breast cancer.

  2005cited by this paper
• 2- and 3-[(Aryl)(azolyl)methyl]indoles as Potential Non-steroidal Aromatase Inhibitors

  2004cited by this paper
• High-throughput docking as a source of novel drug leads.

  2004cited by this paper
• Preparation and pharmacological profile of 7-(alpha-azolylbenzyl)-1H-indoles and indolines as new aromatase inhibitors.

  2003cited by this paper
• Evaluation of the mechanism of aromatase cytochrome P450. A site-directed mutagenesis study.

  2001cited by this paper
• Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen.

  2000cited by this paper
• NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms.

  2000cited by this paper
• New selective nonsteroidal aromatase inhibitors: synthesis and inhibitory activity of 2,3 or 5-(alpha-azolylbenzyl)-1H-indoles.

  1999cited by this paper
• Synthesis and In Vitro Evaluation of 3‐(1‐Azolylmethyl)‐1H‐indoles and 3‐(1‐Azolyl‐1‐phenylmethyl)‐1H‐indoles as Inhibitors of P450 arom

  1997cited by this paper

• Novel chloropyridazine sulfonamides as aromatase inhibitors and apoptotic inducers in breast cancer.

  2025cites this paper
• Development of phenylboronic acid functionalized poly (lactic-co-glycolic acid) nanoparticles for novel co-delivery of chemo-herbal combination towards lung cancer: an in silico and in vitro proof of concept.

  2025cites this paper
• New enantioenriched β‐indolyl ketones as aromatase inhibitors: Unraveling heme–ligand interactions by MD simulation and MMPBSA analysis

  2024cites this paper
• Benzimidazole‐Containing Compounds as Anticancer Agents

  2024cites this paper
• Design and synthesis new indole-based aromatase/iNOS inhibitors with apoptotic antiproliferative activity

  2024cites this paper
• New imidazole derivatives as aromatase inhibitor: Design, synthesis, biological activity, molecular docking, and computational ADME-Tox studies

  2023cites this paper
• Straightforward synthesis of N-arylindoles via one-pot Fischer indolisation–indole N-arylation

  2023cites this paper
• Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors

  2022cites this paper
• Development of an Automated Screen for Kv7.2 Potassium Channels and Discovery of a New Agonist Chemotype.

  2022cites this paper
• New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.

  2021cites this paper
• Antiproliferative activity, enzymatic inhibition and apoptosis-promoting effects of benzoxazole-based hybrids on human breast cancer cells.

  2021cites this paper
• A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors.

  2021cites this paper
• New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study

  2021cites this paper
• Design, Synthesis, In Vitro and In Silico Studies of Some Novel Triazoles as Anticancer Agents for Breast Cancer

  2021cites this paper
• Enantioselective synthesis of indole derivatives by Rh/Pd relay catalysis and their anti-inflammatory evaluation.

  2020cites this paper
• Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor

  2020cites this paper
• Synthesis and docking study of benzimidazole–triazolothiadiazine hybrids as aromatase inhibitors

  2020cites this paper
• Benzoxazole derivatives as new generation of anti-breast cancer agents.

  2020cites this paper
• Nickel-Catalyzed Intramolecular Direct Arylation of Imines toward Diverse Indoles.

  2019cites this paper
• Click chemistry in silico, docking, quantum chemical calculations, and molecular dynamics simulations to identify novel 1,2,4-triazole-based compounds as potential aromatase inhibitors

  2019cites this paper
• Molecular Modeling Of Novel Non-Steroidal Aromatase Inhibitors Containing 1,2,4-Triazole

  2018cites this paper
• Synthesis and Structure–Activity Relationships of Tetrahydro-β-carboline Derivatives as Anticancer and Cancer-chemopreventive Agents

  2018cites this paper
• COMPUTER-AIDED DESIGN OF POTENTIAL AROMATASE INHIBITORS BASED ON 1,2,4-TRIAZOLE DERIVATIVES

  2018cites this paper